Cn /En

News Center

——

Company news

Industry news

InnoModels Biotechnology: Unique Features of CD34+ HSC Platforms

Author:

InnoModels

Release time:

2024-03-27

With the rise of precision medicine, the research and application of Hematopoietic Stem Cells (HSCs) is becoming a hot topic in the medical field. As the source of the hematopoietic system, HSCs have the potential for self-renewal and multidirectional differentiation, and have great potential for the treatment of hematological disorders as well as certain hereditary diseases. With its unique advantages, the CD34+ HSC platform of InnoModels Biotechnology is driving hematopoietic stem cell research and application into a new phase.
First, the CD34+ HSC platform has highly purified hematopoietic stem cells. CD34 is a marker protein on the surface of hematopoietic stem cells, through which researchers can accurately isolate hematopoietic stem cells from complex cell populations. The precision of this technology ensures the reliability and accuracy of subsequent experiments, providing a solid foundation for disease treatment and drug development.
Second, the CD34+ HSC platform enables in vitro expansion of hematopoietic stem cells. Due to the scarcity of hematopoietic stem cells, traditional collection methods are often difficult to meet the needs of research and treatment. However, with the CD34+ HSC platform, researchers can expand hematopoietic stem cells in an in vitro environment, thereby greatly increasing the number of cells to meet experimental and clinical needs.

In addition, the platform has the ability to accurately mimic the in vivo environment. During the in vitro expansion process, researchers can regulate the differentiation and development of hematopoietic stem cells by mimicking the in vivo microenvironment, such as adding specific growth factors and signaling molecules. This precise regulation enables researchers to gain a deeper understanding of the biological properties of hematopoietic stem cells, providing a more accurate basis for disease treatment and drug development.
Finally, the CD34+ HSC platform is important for personalized medicine. Since each person's HSC has a unique genetic background and differentiation potential, the platform allows researchers to tailor personalized treatment plans for patients. This personalized treatment not only improves the therapeutic effect, but also reduces the side effects and risks during the treatment process.
In summary, with its unique advantages of highly purified hematopoietic stem cells, in vitro expansion capability, precise simulation of the in vivo environment, and the potential for personalized medicine, InnoModels' CD34+ HSC platform is opening the door to a new era of precision medicine. With the continuous advancement of technology and the expansion of application fields, it is believed that the platform will bring hope and recovery to more patients in the future.

InnoModels Biotechnology: Key Features of MHC Humanized Mouse Models

InnoModels Biotechnology: Unique Advantages of the iHuPBMC-OncVax Platform

InnoModels Biotechnology: Key Features of MHC Humanized Mouse Models

InnoModels Biotechnology: Unique Advantages of the iHuPBMC-OncVax Platform

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL: +86 15711355061
E-mail: xuyl@imodels.tech
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

InnoModels Biotechnology (Beijing) Co., Ltd

SEO

Business License